Blazar; Bruce

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blazar; Bruce.The latest application filed is for "compositions and methods for preventing and treating graft versus host disease".

Company Profile

3.13.20

Blazar; Bruce - Golden Valley US
Blazar; Bruce - Minneapolis US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Preventing And Treating Graft Versus Host Disease App 20200155656 - Serody; Jonathan ; et al.	2020-05-21
Type 2 Innate Lymphoid Cells And Methods Of Enriching And Growing App 20190125800 - Xing; Yan ; et al.	2019-05-02
Use Of Compositions Modulating Chromatin Structure For Graft Versus Host Disease (gvhd) App 20190000860 - Bradner; James E. ; et al.	2019-01-03
Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells Grant 9,862,928 - Verneris , et al. January 9, 2	2018-01-09
Compositions And Methods For Preventing And Treating Graft Versus Host Disease App 20170360907 - Serody; Jonathan ; et al.	2017-12-21
TALEN-based gene correction Grant 9,393,257 - Osborn , et al. July 19, 2	2016-07-19
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant 9,181,526 - Blazar , et al. November 10, 2	2015-11-10
Talen-based Gene Correction App 20140256798 - Osborn; Mark J. ; et al.	2014-09-11
MAPC Generation of Lung Tissue App 20140234267 - Panoskaltsis-Mortari; Angela ; et al.	2014-08-21
Compositions and Methods for the Treatment of Lysosomal Storage Disorders App 20140212393 - BLAZAR; BRUCE ; et al.	2014-07-31
Generation Of Natural Killer Cells And Lymphoid Tissue Inducer-like (lti-like) Nk-22 Cells App 20140072545 - Verneris; Michael ; et al.	2014-03-13
Mapc generation of lung tissue Grant 8,609,412 - Panoskaltsis-Mortari , et al. December 17, 2	2013-12-17
Cell therapy for the treatment of lysosomal storage disorders Grant 8,580,249 - Blazar , et al. November 12, 2	2013-11-12
Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses App 20120207727 - Blazar; Bruce ; et al.	2012-08-16
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant 8,129,185 - Blazar , et al. March 6, 2	2012-03-06
Compositions and Methods for the Treatment of Lysosomal Storage Disorders App 20110243901 - Blazar; Bruce ; et al.	2011-10-06
Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses App 20100291678 - Blazar; Bruce ; et al.	2010-11-18
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant 7,651,855 - Blazar , et al. January 26, 2	2010-01-26
Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells App 20080317740 - Blazar; Bruce ; et al.	2008-12-25
Mapc Generation of Lung Tissue App 20080274088 - Panoskaltsis-Mortari; Angela ; et al.	2008-11-06
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state Grant 7,368,106 - Murphy , et al. May 6, 2	2008-05-06
Use Of A Promoter Of T-cell Expansion And An Inducer Of Cd40 Stimulation In The Treatment Or Prevention Of A Pathologic State App 20070231299 - Murphy; William J. ; et al.	2007-10-04
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state Grant 7,175,838 - Murphy , et al. February 13, 2	2007-02-13
Compositions and methods for the treatment of lysosomal storage disorders App 20070009500 - Blazar; Bruce ; et al.	2007-01-11
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses App 20050196386 - Blazar, Bruce ; et al.	2005-09-08
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state App 20030068299 - Murphy, William J. ; et al.	2003-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.